Browse the latest stories and reports on MSF from various media outlets.

MSF is raising concerns about trade negotiations that could prevent India from manufacturing affordable, generic versions of newer AIDS medications.

More >

New WHO guidelines for HIV treatment are a major step forward, but they will be a challenge for countries such as South Africa to implement, according to MSF's Dr. Gilles van Cutsem. 

More >

A House subcommittee held a hearing on international trade disputes with India. Most of the event was devoted to U.S. drug company Pfizer's complaints about Indian policies that have fostered the country's billion-dollar generics industry.

More >

South Africa has made major progress in the fight against AIDS since 2001, when MSF was the only organization providing antiretroviral treatment in the country. "Adherence clubs" piloted by MSF now make treatment more accessible than ever.

More >

Access to medicines is a crucial issue in private talks over the Trans-Pacific Partnership, the largest trade deal in U.S. history.

More >

Novartis AG goes to India's Supreme Court on Wednesday to seek patent protection for its blockbuster cancer drug Glivec in a case that could deliver far-reaching ramifications for multinational pharmaceutical companies operating in India.... Novartis's critics, including Médecins Sans Frontières [Doctors Without Borders], say that if the company prevails, it could set a legal precedent that allows pharmaceutical giants to patent a range of drugs in India that are now available from generic producers, including HIV medicines. That would demolish a thriving low-cost industry and lead to higher prices, not just in India, they say, but elsewhere in the developing world where India is a major exporter of drugs.

More >

Hundreds of people marched in New Delhi on Friday to protest an ambitious free-trade agreement being negotiated between India and the European Union that patient groups and health activists say could severely curtail India's production and export of affordable drugs for millions living with HIV in developing countries.

More >

The American Medical Association examines the current financing situation for HIV/AIDS programs in the midst of a persistent global economic crisis.

More >

Of the 33 million people living with AIDS worldwide, only 4 million are on treatment. We have an update from Emi McLean, director of the access to essential medicines campaign for the international humanitarian group Doctors Without Borders.

More >

“The political winds have changed,” said Sharonann Lynch, chief author of the Doctors Without Borders report. “And I don’t believe for a minute it’s just the economic downturn. I think world leaders feel the heat is off and they’re fatigued.”

More >

Pages